Drugs / Bromihexine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01423721 | Aug → Oct 2011 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bromihexine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01423721 ↗ |
| Known as | Bromihexine hydrochloride | “Bromihexine hydrochloride syrup” NCT01423721 ↗ |
| Route | Oral | “Oral Administration” NCT01423721 ↗ |